Literature DB >> 26121151

Metacognitive Deficits in Schizophrenia: Presence and Associations With Psychosocial Outcomes.

Paul H Lysaker1, Jenifer Vohs, Kyle S Minor, Leonor Irarrázaval, Bethany Leonhardt, Jay A Hamm, Marina Kukla, Raffaele Popolo, Lauren Luther, Kelly D Buck, Sara Wasmuth, Giancarlo Dimaggio.   

Abstract

Early formulations of schizophrenia suggested that the disorder involves a loss of ability to form integrated ideas about oneself, others, and the world, resulting in reductions in complex goal-directed behaviors. Exploring this position, the current review describes evidence that persons with schizophrenia experience decrements in their ability to form complex ideas about themselves and to ultimately use that knowledge to respond to psychological and social challenges. Studies are detailed that find greater levels of these impairments, defined as metacognitive deficits, in persons with schizophrenia in both early and later phases of illness as compared with other clinical and community groups. Furthermore, studies linking metacognitive deficits with poorer psychosocial functioning and other variables closely linked to outcomes are summarized. Clinical implications are also discussed.

Entities:  

Mesh:

Year:  2015        PMID: 26121151     DOI: 10.1097/NMD.0000000000000323

Source DB:  PubMed          Journal:  J Nerv Ment Dis        ISSN: 0022-3018            Impact factor:   2.254


  14 in total

1.  Metacognition Is Necessary for the Emergence of Motivation in People With Schizophrenia Spectrum Disorders: A Necessary Condition Analysis.

Authors:  Lauren Luther; Kelsey A Bonfils; Ruth L Firmin; Kelly D Buck; Jimmy Choi; Giancarlo Dimaggio; Raffaele Popolo; Kyle S Minor; Paul H Lysaker
Journal:  J Nerv Ment Dis       Date:  2017-12       Impact factor: 2.254

2.  Metacognitive Deficits Predict Impaired Insight in Schizophrenia Across Symptom Profiles: A Latent Class Analysis.

Authors:  Paul H Lysaker; Emily Gagen; Abigail Wright; Jenifer L Vohs; Marina Kukla; Phillip T Yanos; Ilanit Hasson-Ohayon
Journal:  Schizophr Bull       Date:  2019-01-01       Impact factor: 9.306

3.  Insight in schizophrenia spectrum disorders: relationship with behavior, mood and perceived quality of life, underlying causes and emerging treatments.

Authors:  Paul H Lysaker; Michelle L Pattison; Bethany L Leonhardt; Scott Phelps; Jenifer L Vohs
Journal:  World Psychiatry       Date:  2018-02       Impact factor: 49.548

Review 4.  Predictive Processing, Source Monitoring, and Psychosis.

Authors:  Juliet D Griffin; Paul C Fletcher
Journal:  Annu Rev Clin Psychol       Date:  2017-03-30       Impact factor: 18.561

Review 5.  Clozapine in Reducing Aggression and Violence in Forensic Populations.

Authors:  Kathleen Patchan; Gopal Vyas; Ann L Hackman; Marie Mackowick; Charles M Richardson; Raymond C Love; Ikwunga Wonodi; MacKenzie A Sayer; Matthew Glassman; Stephanie Feldman; Deanna L Kelly
Journal:  Psychiatr Q       Date:  2018-03

6.  Disembodied Language in Early-Onset Schizophrenia.

Authors:  Przemysław Zakowicz; Maria Skibińska; Joanna Pawlak
Journal:  Front Psychiatry       Date:  2022-07-05       Impact factor: 5.435

Review 7.  Cognitive remediation in schizophrenia-The view from India.

Authors:  Smita N Deshpande; Triptish Bhatia; E Mohandas; Vishwajit L Nimgaonkar
Journal:  Asian J Psychiatr       Date:  2016-06-24

8.  Atypical functional connectivity in resting-state networks of individuals with 22q11.2 deletion syndrome: associations with neurocognitive and psychiatric functioning.

Authors:  Leah M Mattiaccio; Ioana L Coman; Matthew J Schreiner; Kevin M Antshel; Wanda P Fremont; Carrie E Bearden; Wendy R Kates
Journal:  J Neurodev Disord       Date:  2016-01-21       Impact factor: 4.025

9.  Impact of Different Childhood Adversities on 1-Year Outcomes of Psychotic Disorder in the Genetics and Psychosis Study.

Authors:  Antonella Trotta; Robin M Murray; Anthony S David; Anna Kolliakou; Jennifer O'Connor; Marta Di Forti; Paola Dazzan; Valeria Mondelli; Craig Morgan; Helen L Fisher
Journal:  Schizophr Bull       Date:  2015-09-15       Impact factor: 9.306

10.  A multicenter, randomized controlled trial of individualized occupational therapy for patients with schizophrenia in Japan.

Authors:  Takeshi Shimada; Manami Ohori; Yusuke Inagaki; Yuko Shimooka; Naoya Sugimura; Ikuyo Ishihara; Tomotaka Yoshida; Masayoshi Kobayashi
Journal:  PLoS One       Date:  2018-04-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.